Share prices for high-tech alternative medicine company BioTech Medics (OTCBB: BTME) were up 6.25 percent today to 5 cents a share after the market’s open. The boost seems to come from new work the company has done on its chief product, the BioTech L3aser.”The most important thing is that we’ve gone through 10 years of research and development for our laser to be used for muscular, skeletal and arthritic pain,” BioTech Medics CEO Keith Houser told MN1. “It’s fabulous … for people with backaches, carpal tunnel, migraines – anything in the body can be treated for pain without drugs, without surgery.”
According to Houser, the laser and its associated L3aser Protocol Therapy is “effective, economical, non-surgical, drug-free pain management,” and works by affecting the miochondrial level of the cell.
“[The beam] actually activates the cell, if damaged, to heal itself, or if it’s not damaged, to accelerate its [healing] capacity,” Houser said. “It actually releases natural endorphins in your body.”
Billing itself as an “alternative medicine for the twenty-first century,” BioTech Medics is responsible for a number of innovations. For example, BioTech is the patent holder of SHBAN Hand Sanitizer, a non-toxic antimicrobial that has been “clinically proven” to kill the Avian Bird Flu Virus along with common germs and bacteria.
The laser isn’t the only thing the company has been working on. In addition to expanding on the laser work, the company is looking to expand its geographic footprint as well.
“Well, we have four up-and-running centers and more on the drawing board,” Houser said. “It’s a matter of expanding the company to meet those needs.”